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There are several areas of healthcare and well-being 
that could be enhanced using blockchain technologies. 
These include device tracking, clinical trials, 
pharmaceutical tracing, and health insurance. Within 
device tracking, hospitals can trace their asset within a 
blockchain infrastructure, including through the 
complete lifecycle of a device. The information gathered 
can then be used to improve patient safety and provide 
after-market analysis to improve efficiency savings. This 
paper outlines recent work within the areas of 
pharmaceutical traceability, data sharing, clinical trials, 
and device tracking. 
lockchain is a distributed ledger technology, 
with the potential to disrupt many industries. 
Indeed, with $1.4 billion invested in blockchain 
related startups in 2016;1 and with this projected to grow 
further in 2017 the hype cycle shows no sign of slowing. 
At the time of writing, a lot of the attention around 
blockchain has centered on cryptocurrency, 
predominantly Bitcoin2 and the effect that blockchain is 
predicted to have on the financial sector. This effect led 
to the established consultancy Accenture labeling it as 
one of three technologies that will change the financial 
services world.3 Despite this focus on financial services,  
there are many other areas prime for disruption including 
voting,4 real estate,5 supply chain management,6 and of 
course, healthcare.7 Healthcare is prime for disruption as 
it has a variety of problems in the industry that 
blockchain can solve through its immutability, fraud 
prevention and capability to share data between 
organizations without requiring trust. Current issues 
within modern healthcare industry are listed in Table 1.  
A key challenge, as identified by Frost & Sullivan,8 is to 
tag medical equipment with a usable ID and in 
integrating trust in device identification and tracking. 
When a device, such as an infusion pump is shown to 
have malfunctioned, the tracking of the device can reveal 
the source of the problem and prevent unnecessary 
repurchasing in the case of lost devices. A strong trust 
infrastructure based around the identification of medical 
devices is likely to reduce these threats. The report 
estimates that only 20% to 30% of medical devices are 
connected within hospitals due to security and privacy 
issues. 
Within the pharmaceutical industry, blockchain can help 
overcome the increasing risks around counterfeit and 
unapproved drugs. As with device tracking, it is possible 
to define smart contracts for drugs and then identify pill 
containers, with integrated GPS and chain-of-custody 
logging. 
B 
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Data must pass between healthcare 
providers to necessary third 
parties, insurers, and patients 
while meeting data protection 
regulation in the healthcare sector. 
Nationwide 
Interoperability 
Having a single standard for 
patient data exchange allows for 
ease of passing data between 
healthcare providers, which legacy 
systems often do not provide. 
Medical Device 
Tracking 
Medical device tracking from 
supply chain to decommissioning 
allows for swift retrieval of 
devices, prevention of unnecessary 
repurchasing, and fraud analytics. 
Drug Tracking As with medical devices, 
blockchain offers the capability to 
track the chain of custody from 
supply chain to patients, allowing 
for frictionless recalls and 
prevention of counterfeit drugs. 
 
Within clinical trials, blockchain can be used to 
overcome the problems of fraudulent results and 
removal of data, which do not support the researcher’s 
bias or funding source’s intention. This will enforce 
integrity in clinical trials. In addition, it allows an 
immutable log to be kept of trial subject consent. It is 
thought that the pharmaceutical industry could benefit 
with savings of $200 billion in defining a chain-of-
custody in the supply chain.8 
 
With health insurance, many areas could benefit from a 
trusted record of events around the patient pathway, 
including improved reporting around incidents and 
automating underwriting activities. Contracts could also 
be clearly defined and then enacted, such as automated 




A blockchain is ostensibly a chain of blocks secured by 
cryptographic techniques. One of the features most 
appealing about this to many industries is its 
immutability. Data added to the blockchain cannot be 
modified; and therefore, a consensus-based, verifiable 
and correct ledger of data can be created. This makes 
blockchain particularly suited to tasks where data 
integrity is of utmost importance, a practical example of 
this immutability is ProvChain,9 an architecture built on 
the blockchain for providing chain-of-custody for data 
objects on the cloud.  
 
There are multiple implementations of the blockchain, 
these include Bitcoin,2 the cryptocurrency token 
implemented on the Blockchain; Ethereum,10 the 
blockchain-based ledger that features a Turing-complete 
virtual machine allowing execution of code on the 
blockchain using smart contracts; and JP Morgan’s 
Juno,11 an Ethereum fork using a different consensus 
method known as Quorum as well as many other 
blockchain implementations.  
 
Consensus methods is one of the ways in which 
blockchain implementations differ. Bitcoin, for example, 
uses a Proof-Of-Work algorithm known as HashCash,12 
and is an intentionally expensive algorithm originally 
designed prevent denial-of-service attacks. All Bitcoin 
miners validate the blockchain by performing this proof-
of-work algorithm as a vote towards the consensus on 
the blockchain. Ethereum also uses a Proof-of-Work 
algorithm, Ethash,13 as addressed in the Ethereum 
Yellow Paper,10 based on the Dagger-Hashimoto 
algorithm.14 Ethereum will, however, move to a Proof-
Of-Stake Algorithm, Casper, in the future. This is to 
address the extreme energy requirements of Proof-Of-
Work, made clear by both Ethereum and Bitcoin using 
similar amounts of electricity to all of Ireland.15 
 
Ethereum also differs from Bitcoin due to its 
implementation of smart contracts. Smart contracts are 
pieces of code executed on every node on the 
blockchain. They are self-executing contracts in which 
the agreement is enforced on all members of the 
blockchain. They set out the benefits, obligations and 
penalties associated with behavior related to the contract 
like the way a traditional contract works. As they mimic 
traditional paper contracts and laws, they can be used, 
for example, to model the HIPAA healthcare personal 
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health information (PHI) workflow to meet regulatory 
and audit requirements, such as is implemented within 
Patientory.16 
 
A different type of blockchain trust model is also 
emerging, that of trust in the consortium. Microsoft has 
recently developed a framework named Coco which 
allows for blockchain agnostic consortiums to be 
created.17 These consortium models rely on a pre-defined 
group of trusted parties. In healthcare this may be 
multiple hospitals or in the UK, NHS Trusts, as well as 
medical device manufacturers and third parties.  
 
By executing smart-contracts solely on these trusted 
partner’s hardware, consensus is generated without the 
need for miners. This has resulted in a significantly 
greater performance with a Coco-optimized blockchain 
instance able to process 1600 transactions per second, a 
performance improvement bringing blockchain much 
closer to the big payment processors.18 Coco is also 
agnostic of trusted execution environments allowing the 
use of Intel Software Guard Extensions, Windows 
Virtual Secure Mode and Arm TrustZone among others. 
 
Clinical Trials 
Clinical trials and the management of trial subject 
consent are an area where blockchain has the potential to 
increase transparency, auditability and accountability of 
medical practitioners and researchers.19 
 
By maintaining an immutable log of patient consent, 
regulators can easily monitor clinical trial standards, 
ensuring that the trial meets the country’s informed 
consent regulations. This is particularly important as 
fabricated informed consent forms have been among the 
most common type of clinical fraud.20 this includes 
editing records and falsifying patient consent, which 
indicates that a level of trial subject authentication would 
be required to prevent this. This system could be further 
augmented; as proposed by Benchoufi, Porcher and 
Ravaud,21 implementing a smart contract system that 
prevents clinicians from using patient data until a key 
has been released at the end of an auditable smart 
contract process requiring consent at each stage of the 
trial. This process should also allow for the revocation of 
patient consent. Implementing a blockchain clinical trial 
consent log gives clinical trial subjects ownership of 
their own data while providing an audit trail for clinical 
staff, researchers, and regulators. 
 
Data Sharing 
Data sharing represents one of the greatest opportunities 
for improvements in healthcare but also one of the 
largest privacy challenges. Indeed, Powles and Hodson22 
address the need to provide transparency on how patient 
data are shared with 3rd parties using the case study of 
the DeepMind collaboration with Royal Free London 
NHS Foundation Trust. The lack of patient consent in 
the previous case study is addressed as one of the most 
significant issues, despite the positive effect Google’s 
product suite had on patient diagnosis and treatment. On 
the opposite end of the spectrum, IBM and the American 
Sleep Apnea Association23 are using IBM’s Watson 
supercomputer to study sleep apnea in thousands of 
Americans at home, with clear and informed consent 
from patients to solve major challenges in healthcare. 
 
It is important to have a nationwide standard for 
interoperability in IT services in healthcare. This has 
been underlined in a UK NHS white paper written by 
Wachter and Hafter24 in a comparison with the U.S. 
healthcare system, which underlined the importance of 
interoperability in allowing access to patient Electronic 
Health Records (EHRs) across multiple hospitals, as 
many trusts have different systems built by different 
vendors for accessing these records. And as shown in the 
U.S., this creates issues for doctors and nurses. Social 
care and mental health are reported as having suffered as 
in both the U.S. and UK it is still mostly paper-based.  
 
Medical device asset tracking is a current problem 
within the healthcare sector. A report by Harland 
Simon25 on a project justifying RFID tagging in NHS 
Cambridgeshire asserted that 15% of a hospital’s assets 
are lost every year, representing a significant cost in 
repurchasing items the hospital already has. 
Additionally, according to a report published by GE 
Healthcare [26] nurses spend an average of 21 minutes 
per shift searching for devices and beds that have been 
misplaced with many hospitals, according to the study, 
defining any device below $5000 consumable and to be 
repurchased if they can’t be found representing 
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significant cost in the sector. By adopting radio-
frequency identification (RFID) standards for medical 
device tracking, NHS Forth Valley in Scotland, 
according to another study published by Harland 
Simon27 were able to save almost £400,000 in cost 
avoidance due to not having to purchase significant 
medical devices that would have otherwise been lost to 
the system.  
 
Drug tracking is a different problem entirely to medical 
device tracking, as the main concern is counterfeit drugs. 
A study by the WHO28 identified that as many as 10% of 
the pharmaceutical supply in the U.S. is counterfeit. The 
Food and Drug Administration (FDA) in the US recently 
endorsed the use of RFID to track pharmaceuticals from 
the supply chain to the patient. This allows the complete 
chain of custody to be monitored, ensuring that the 
hospitals have bought the pharmaceuticals from a 
legitimate source. Pfizer29 was the first pharmaceutical 
company to adopt RFID “e-pedigree” where patients and 
doctors could trust the source and capabilities of their 
flagship medicine, Viagra, as they identified that it was 
among their most counterfeited drugs. This system has 
allowed wholesalers and pharmacists to verify the 
authenticity of their Viagra using a simple RFID scanner 
with the cost to Pfizer being low due to the use of low-
cost passive RFID tags & barcodes. 
 
Patient Records 
Blockchain has significant power to disrupt healthcare 
and put data in the hands of patients. One particularly 
interesting move towards this is MedRec,30 which gives 
patients and doctors an immutable log of healthcare 
records. It takes a different approach to incentivization 
for miners by giving access to anonymized healthcare 
data in exchange for sustaining the network. MedRec 
uses Smart Contracts to map Patient-Provider 
Relationships (PPRs) where the contract shows a list of 
references detailing the relationships between nodes on 
the Blockchain. It also puts PPRs in the hands of the 
patient, giving them the ability to accept, reject, or 
modify relationships with healthcare providers such as 
hospitals, insurers, and clinics.  
 
Blockchain offers an opportunity for interoperability in 
healthcare systems as having a decentralized ledger of 
accepted fact in medical records where all healthcare 
providers have access to this ledger. This means that 
though the user-interfaces may be different, their central 
ledger will be identical across all providers. A challenge 
that exists relates to the current state of health records 
across providers, which contain significant amounts of 
the same information under different identifiers that may 
not be linked. This creates duplication and as the 
blockchain grows, the performance degrades and this 
level of replication of data across records would require 
deduplication to maintain a reasonably performant 
system with unique, anonymized identifiers to identify 
patients across all services. This is a business challenge 
in and of itself of adopting a blockchain health record, it 
is important to note that health records would not start 
from zero as they would have to replace the existing 
system which creates challenges.  
 
Additionally, the sheer volume of data generated in 
healthcare environments, which is only set to increase 
further, with Kaiser Permanente believed to have 
between 26 and 44 petabytes of data on its 9 million 
members from EHRs and other medical data in 2014.31 
The volume of data logged and referenced to will only 
add to this scalability problem. 
 
Drug Tracking 
Drug tracking on the blockchain is another opportunity 
as it leverages the immutability of the blockchain to 
develop tracking and chain of custody from 
manufacturer to patient. Chronicled is a technology start-
up company developing their product, Discover,32 which 
creates a chain of custody model showing where the 
drug was manufactured, where it has been since, and 
when it has been disbursed to patients, leveraging the 
immutability of the blockchain to prevent fraud and theft 
of pharmaceuticals. This allows healthcare providers to 
meet current healthcare standards regarding 
pharmaceutical supply security, again with an emphasis 
on interoperability between healthcare providers.  
Hyperledger,33 the Open-Source Blockchain Working 
Group, recently launched the Counterfeit Medicines 
Project34 focusing on the problem of counterfeit 
pharmaceuticals. Using Blockchain, the origins of 
counterfeit medicines can be traced and removed from 
the supply chain. 
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The advantage of blockchain in drug tracking over 
traditional means is the decentralization of trust and 
authority inherent in the principles behind the 
technology, where central authorities can be bribed or 
faked it is much harder to bribe a consensus of those on 
the blockchain. For this reason, the current industry 
standard in pharmaceutical tracking, ePedigree,29 which 
currently uses RFID and a traditional database is moving 
towards their own blockchain solution. If 
pharmaceuticals can be modified and tracked using 
blockchain’s inherent anti-tampering capabilities at the 
point of manufacture, counterfeit pharmaceuticals can be 
completely removed from participating supply chains. 
 
Device Tracking 
Medical device tracking is another opportunity for the 
blockchain in disrupting healthcare from manufacturer to 
decommissioning. The monetary savings created by 
asset tracking are clear, NHS East Kent Hospital found 
that as a result of a case study by Harland Simon35 in 
which they implemented active RFID trackers on their 
high waste equipment they found 98 infusion pumps 
they had no idea they still owned across three sites. At a 
cost of $1,500 each they saved $147,000 due to this 
single case study. The use of the blockchain along with 
this technology offers the opportunity for an immutable 
ledger, which shows not only where the device is but 
where it has been in its lifecycle, as well as which 
manufacturer, reseller, and the serial number are 
associated with the device, aiding regulatory 
compliance. This capability was addressed by Deloitte7 
in a white paper as one of the potential game-changers 
for blockchain in the healthcare sector. Indeed, an IBM 
study36 showed that 60% of government stakeholders in 
healthcare believe that medical device integration and 
asset management are the greatest areas for disruption in 
the sector. 
 
A blockchain approach offers several benefits over 
traditional location tracking products. The most obvious 
of which is the immutability and tamper-proof qualities 
of the Blockchain. This prevents a malicious user from 
changing the location history of a device or deleting it 
from record. This is particularly important factor 
considering that medical device theft and shrinkage has 
become a multi-million-dollar problem both in the US 
and the UK.37,38  
 
As well as traditional theft, this immutability also 
prevents devices being lost and reordered, which incurs a 
significant cost both in terms of the care provided and in 
actual equipment costs. This system should not add 
significant additional workload to a nurse, porter or 
support worker, as it would only require a tap on the 
device with the mobile phone or scanner and then 
entering of the current location of the device. 
 
While the application of blockchain within the Internet 
of Things (IoT) is fast developing, Huh39 defines a way 
for devices to intercommunicate through an Ethereum 
blockchain and use an RSA public key system. In this 
way, a device stores their public key on the blockchain 
and the associated private key is stored on the device.  
 
CONCLUSIONS 
Proofs of concept have been developed which bring 
blockchain technologies into the healthcare industry 
however there are still many barriers to adoption. One of 
the most significant barriers will be the inherent 
resistance of the healthcare industry to change its current 
practices,40 especially relating to organizational, 
structural, technological, and human factors. 
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